Navigation Links
Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
Date:10/17/2007

SOUTH SAN FRANCISCO, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that its lead product candidate, picoplatin, has been granted orphan medicinal product designation for the treatment of small cell lung cancer (SCLC) by the European Commission. This designation is based on a recommendation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA).

Picoplatin is currently being studied in the pivotal Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial in SCLC, which is evaluating overall survival as the primary endpoint and is being conducted under a Special Protocol Assessment (SPA) agreement with the FDA.

"The receipt of orphan drug designation in the EU for picoplatin for the treatment of small cell lung cancer is an important achievement and builds on our success of obtaining orphan drug designation for picoplatin in the U.S.," said Jerry McMahon, Ph.D., chairman and CEO of Poniard. "Because many SCLC patients who are treated with platinum therapies relapse quickly or do not respond at all, new therapies that are active in this disease and that can overcome platinum resistance are urgently needed. We are committed to bringing picoplatin to market in the U.S. and the EU for this severely underserved patient population and are making significant progress in enrolling patients in our pivotal SPEAR trial for this indication."

About Orphan Drug Designation in the European Union

The EU orphan medicinal product designation aims to encourage the development of drugs involved in the diagnosis, prevention or treatment of a life-threatening or chr
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. Speaker announces business members of IT Task Force
4. Doyle announces technology tax credits for Berbee
5. Doyle announces new energy, global warming policies
6. Doyle announces $80M renewable energy strategy
7. GE announces first installation of Discovery VCT
8. UWM announces winners of RGI awards
9. Third Wave announces two senior management appointments
10. Mirus announces new method for making antibodies
11. Merge announces sofware updates, upcoming acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Shimadzu Scientific Instruments has released the DSES-1000 long-travel ... for measuring displacement in rubber and other soft ... distance, the DSES-1000 can measure elongations up to ... mm. In addition, it achieves +/- 0.2 percent ... +/- 100 µm below 50-mm stroke. , The ...
(Date:9/30/2014)... 30, 2014 Follow us on ... each type of cholesterol carrier or lipoprotein in the ... excessive cholesterol levels in the body, especially along the ... heart attack and other cardiovascular disorders. Cardiovascular Diseases (CVD) ... for cholesterol levels on a regular basis, to assess ...
(Date:9/30/2014)... Basel, Switzerland (PRWEB) September 30, 2014 ... advanced software solutions for drug discovery and ... the FUNGITECT consortium has chosen Genedata Selector ... next-generation sequencing (NGS) data. FUNGITECT is a ... of invasive fungal diseases via individualized anti-fungal ...
(Date:9/30/2014)... , Sept. 30, 2014 FemCap Inc., ... announces its receipt of a patent No: US, 8,795,248 ... has also received FDA clearance in the U.S., 510(K) ... CE in Europe. This patent is related to its menstrual ... issuance, the company is releasing FemmyCycle Teen, a third ...
Breaking Biology Technology:Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 2Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 3Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. 4FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 2FUNGITECT Consortium Adopts Genedata Selector as Data Analysis Platform for Anti-fungal R 3The FemmyCycle 2
... May 27 CellCyte Genetics,Corporation (CellCyte) (OTC ... provide shareholders, potential investors and journalists,with accurate ... Room powered Web site: http://www.cellcyte.com ... or sources for stories from,CellCyte can access ...
... that the application,form for the 2008 Protein Tomography(TM) ... application will be offered a Protein Tomography(TM),study in ... in the range of 0.1 and 0.5 million ... http://www.newscom.com/cgi-bin/prnh/20080220/294289 ), The Protein Tomography(TM) ...
... Online Tool Helps Pair Dialysis Patients with Compatible ... DaVita Inc., a leading,provider of kidney care ... disease (CKD), recently introduced "Treatment Evaluator", an,interactive online ... modalities DaVita(R) offers, and encourage patients to engage ...
Cached Biology Technology:The Protein Tomography(TM) Award Now Published on Sidec's Homepage 2DaVita Introduces 'Treatment Evaluator' 2
(Date:9/29/2014)... Parents with children at home should use ventilation when ... University are recommending, after a new study showed an ... symptoms and chronic bronchitis. , "In homes where a ... asthma and wheezing is higher than in homes where ... Smit, an associate professor in the College of Public ...
(Date:9/29/2014)... a bad rap, and understandably so. The grain-of-rice-sized insects ... millions of acres in the Western U.S. and Canada ... popular belief, these pests may not be to blame ... swept through the region. Instead, weather and topography play ... than these bark-boring beetles. , New research led by ...
(Date:9/29/2014)... Manuel Santos has presented Dr. Cristin Samper, president ... the prestigious Order of San Carlos. , The ... civilians and military officers who have made outstanding ... of international relations. , An international authority on ... invited to the Colombian Residence in New York ...
Breaking Biology News(10 mins):Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 2Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 3Tree killers, yes, fire starters, no: Mountain pine beetles get a bad rap, study says 4
... 2012) The latest conference to be sponsored ... the molecular mechanisms involved in exercise-mediated physiological changes ... dynamic molecular and cellular pathways. Entitled Integrative Biology ... October 10-13, 2012 in Westminster, Colorado. The full ...
... million to Emory University,s Center for Selective C-H Functionalization, ... the country working to revolutionize the field of organic ... a huge impact on the development of new drugs ... organic synthesis, and making it faster, simpler and greener," ...
... Environment Initiative (E2I), a sweeping plan to support interdisciplinary ... the university to work with Houston,s energy industry to ... current and alternative forms of energy. "One of ... the challenge of meeting the world population,s escalating need ...
Cached Biology News:American Physiological Society's latest conference focuses on integrative biology of exercise 2American Physiological Society's latest conference focuses on integrative biology of exercise 3Emory receives $20 million NSF grant for chemistry center 2Emory receives $20 million NSF grant for chemistry center 3Emory receives $20 million NSF grant for chemistry center 4Rice launches sweeping Energy and Environment Initiative 2Rice launches sweeping Energy and Environment Initiative 3Rice launches sweeping Energy and Environment Initiative 4Rice launches sweeping Energy and Environment Initiative 5
Mouse monoclonal antibody to UGT2B10 - UDP glucuronosyltransferase 2 family, polypeptide B10...
Mouse polyclonal antibody raised against a partial recombinant COASY. NCBI Entrez Gene ID = 80347...
... is intended for first-time users of the PROTEAN ... includes a protein sample and reagents sufficient to ... 17 cm, ten 11 cm, or sixteen 7 ... precast SDS-PAGE gels and gels stains are not ...
... Phosphate Phosphatase 2 (LPP2) ... aqueous solution Solution ... containing 0.08% sodium azide. ... the human LPP2 protein. ...
Biology Products: